Herbal supplement usage among cancer patients: A questionnaire-based survey
- PMID: 33723144
- DOI: 10.4103/jcrt.JCRT_612_18
Herbal supplement usage among cancer patients: A questionnaire-based survey
Abstract
Background: Herbal supplements (HS) are one of the most commonly used complementary and alternative medicines in cancer. Reduced therapeutic efficacy of prescription anticancer agents through unwarranted herb-drug interactions is a major efficacy/safety concern. In view of the rising cancer prevalence in India along with a high degree of reliance and cultural acceptability in favor of traditional medicine drugs, prevalence data exclusively of HS usage during cancer treatment are of considerable epidemiological significance.
Methodology: This questionnaire-based prospective observational study aimed at estimating the prevalence of HS among cancer patients during treatment at our tertiary care medical center. Taken on a population of 220 patients within a period of 9 months, data were generated by a customized validated questionnaire and the same processed by IBM SPSS Statistics for Windows, version XXIV, Armonk, NY: IBM Corp. Differences between HS use and nonuse with respect to demographic, disease, and treatment characteristics were assessed by Chi-square test. For examining the latter variables as possible predictors of HS usage, they were entered into bivariate logistic regression with odds ratio and confidence intervals calculated for each.
Results: Out of 220 patients, 57 (26%) were HS users and 163 (74%) were nonusers. Majority of the users (42.1%) were on self-prepared folklore herbal medicine postdiagnosis of cancer (57.9%), the most common reason cited being symptom palliation (35.1%) on the advice of friends and family (64.9%). Fear of disapproval was the most common reason cited (68.4%) for not disclosing HS usage to the physician.
Conclusion: Chemotherapy and unemployment are predictors of HS usage, and there is a significant association between occupation status and HS usage. This first study on HS prevalence among South Indian population proposes the need for a more robust evidence base for understanding all aspects of HS use in cancer.
Keywords: Chemotherapy; Tamil Nadu; complementary and alternative medicine; herbal supplements; questionnaire.
Conflict of interest statement
None
Similar articles
-
The prevalence of herbal medicine among Sudanese adults: a cross-sectional study 2021.BMC Complement Med Ther. 2024 Aug 14;24(1):308. doi: 10.1186/s12906-024-04584-1. BMC Complement Med Ther. 2024. PMID: 39143562 Free PMC article.
-
Knowledge and characteristics of herbal supplement usage among community pharmacy customers in a Malaysian population.Complement Ther Med. 2017 Dec;35:92-108. doi: 10.1016/j.ctim.2017.09.005. Epub 2017 Oct 13. Complement Ther Med. 2017. PMID: 29154074
-
Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.Br J Gen Pract. 2018 Oct;68(675):e711-e717. doi: 10.3399/bjgp18X699101. Br J Gen Pract. 2018. PMID: 30249608 Free PMC article.
-
Family medicine physicians' perception and attitudes of herbal substances use in greater Lisbon region.Phytomedicine. 2018 Aug 1;47:1-11. doi: 10.1016/j.phymed.2018.04.040. Epub 2018 Apr 17. Phytomedicine. 2018. PMID: 30166093
-
The prevalence of usage of herbal medicines among cancer patients.J BUON. 2013 Oct-Dec;18(4):1048-51. J BUON. 2013. PMID: 24344037
Cited by
-
US South Asian Youths' Perspectives on the Use of Complementary and Alternative Medicine (CAM).J Racial Ethn Health Disparities. 2024 Aug;11(4):2044-2054. doi: 10.1007/s40615-023-01672-9. Epub 2023 Jun 27. J Racial Ethn Health Disparities. 2024. PMID: 37368189
-
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.J Cancer Res Clin Oncol. 2023 Jul;149(7):2855-2882. doi: 10.1007/s00432-022-04172-1. Epub 2022 Jul 6. J Cancer Res Clin Oncol. 2023. PMID: 35790560 Free PMC article.
-
Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study.Cancers (Basel). 2023 Jun 15;15(12):3190. doi: 10.3390/cancers15123190. Cancers (Basel). 2023. PMID: 37370800 Free PMC article.
-
Traditional and Complementary Medicine Use among Cancer Patients in Asian Countries: A Systematic Review and Meta-Analysis.Cancers (Basel). 2024 Sep 11;16(18):3130. doi: 10.3390/cancers16183130. Cancers (Basel). 2024. PMID: 39335102 Free PMC article. Review.
-
Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.Nutrients. 2024 Feb 23;16(5):623. doi: 10.3390/nu16050623. Nutrients. 2024. PMID: 38474751 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical